Skip to main content

Table 5 Adverse reactions after vaccination

From: Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

  

Local

Systemic

Pain

Redness

Swelling

Pruritus

Fatigue

Headache

Muscle pain

Coldness

Fever

Arthralgia

Nausea

Diarrhea

Stomachache

Anaphylaxis

All

First vaccine

Control (n = 121)

67

11

14

15

23

7

32

2

7

3

0

3

2

0

 

HD (n = 208)

107

13

19

19

24

5

52

3

5

7

5

5

1

0

 

p value

0.49

0.34

0.48

0.35

0.06

0.11

0.77

0.88

0.11

0.65

0.09

0.97

0.28

> 0.99

Second vaccine

Control (n = 121)

61

12

17

24

27

14

30

4

21

5

0

0

0

0

 

HD (n = 208)

109

15

21

26

50

23

52

16

57

16

9

4

4

0

 

p value

0.73

0.39

0.28

0.07

0.72

0.89

0.97

0.11

0.039

0.20

0.020

0.12

0.12

> 0.99

Male

First vaccine

Control (n = 74)

40

4

5

5

10

5

15

0

4

1

0

3

2

0

 

HD (n = 134)

62

5

5

9

11

3

35

2

5

6

2

2

1

0

 

p value

0.28

0.56

0.32

0.71

0.22

0.11

0.35

0.29

0.57

0.23

0.29

0.25

0.26

> 0.99

Second vaccine

Control (n = 74)

34

4

4

9

14

7

14

1

10

4

0

0

0

0

 

HD (n = 134)

65

7

9

12

26

12

33

9

36

14

7

2

3

0

 

p value

0.72

0.96

0.71

0.46

0.93

0.90

0.35

0.08

0.026

0.21

0.046

0.29

0.19

> 0.99

Female

First vaccine

Control (n = 46)

27

7

9

10

13

2

17

2

3

2

0

0

0

0

 

HD (n = 73)

45

8

14

10

13

2

17

1

0

1

3

3

0

0

 

p value

0.75

0.50

0.96

0.25

0.18

0.63

0.11

0.31

0.027

0.31

0.16

0.16

> 0.99

> 0.99

Second vaccine

Control (n = 46)

27

8

13

15

13

7

16

3

11

1

0

0

0

0

 

HD (n = 73)

44

8

12

14

24

11

19

7

21

2

2

2

1

0

 

p value

0.86

0.32

0.12

0.10

0.60

0.98

0.31

0.56

0.56

0.85

0.26

0.26

0.43

> 0.99

  1. HD, hemodialysis
  2. Statistically significant parts with p < 0.05 were shown in bold